| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/22/2004 | WO2003045326A3 Method for preparing and using polyoxyethylated castor oil in pharmaceutical compositions |
| 01/22/2004 | WO2003026570A3 Reduced toxicity cisplatin formulations and methods for using the same |
| 01/22/2004 | WO2003025121A3 Igf-binding protein-derived peptide or small molecule |
| 01/22/2004 | WO2003024421A3 Triclosan dosage form |
| 01/22/2004 | WO2003024395A8 Linked biaryl compounds |
| 01/22/2004 | WO2003024390A3 Hydroxyeicosenoic acid analogs |
| 01/22/2004 | WO2003008595A3 Novel oligoribonucleotide derivatives for the targeted inhibition of gene expression |
| 01/22/2004 | WO2002092573A3 Heterocyclic substituted pyrazoles as inhibitors of src and other protein kinases |
| 01/22/2004 | WO2002085362A3 Dermatological composition comprising nicotinic acid or an amide, and a sphingoid base |
| 01/22/2004 | WO2002076439A3 Compounds capable of modulating the activity of multidrug transporters and therapeutic use of the same |
| 01/22/2004 | WO2002072093A3 Use of dual h3/m2 antagonists with a bipiperidinic structure in the treatment of cognition deficit disorders |
| 01/22/2004 | WO2002070464A3 Hydrazones and their therapeutic use |
| 01/22/2004 | WO2002065986A3 Transporters comprising spaced arginine moieties |
| 01/22/2004 | US20040016006 Chromosome 3p21.3 genes are tumor suppressors |
| 01/22/2004 | US20040015214 Photodynamic therapy for the treatment of hair loss |
| 01/22/2004 | US20040015037 Radioactive member and method of making |
| 01/22/2004 | US20040014998 Process for the preparation of baccatin III derivatives |
| 01/22/2004 | US20040014992 A dichlorobenzylcyanide or a dichlorophenylcyclohexyl acetic acid methyl ester; use as antagonist of serotonin receptor and dopamine, treating attention deficit hyperactivity disorder, Parkinson's disease, nervous system disorders |
| 01/22/2004 | US20040014983 Chlorinating benzisoxazole methane sulfonic acid with thionyl chloride to form an intermediate of benzisoxazole methane sulfonamide |
| 01/22/2004 | US20040014982 For use as fungicides or cytostatic agents |
| 01/22/2004 | US20040014979 For use as antitumor agents |
| 01/22/2004 | US20040014978 Such as (4S,7R,8S,9S,13(Z),16S(Z))-4,8-Dihydroxy-16-(1-fluoro-2-(2-methyl-4 -thiazolyl)ethenyl)-1-oxa-5,5,7,9,13-pentamethyl-cyclohexadec-13-ene-2,6 -dione |
| 01/22/2004 | US20040014976 Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
| 01/22/2004 | US20040014975 For contraception, treatment of hormone-related (aging) conditions, and sexual dysfunction |
| 01/22/2004 | US20040014973 Pyridin-4-YL or pyrimidin-4-YL substituted pyrazines |
| 01/22/2004 | US20040014972 Such as 4-(4-(quinolin-8-yl)piperazin-1-yl)-1-(4-fluorophenyl) butan-1-one trichloride dihydrate; HT3 receptor antagonists |
| 01/22/2004 | US20040014971 N-(4-(4-(2-oxo-1-phenyl-2-((2,2,2-trifluoroethyl)amino)ethyl)-1 -piperazinyl)-phenyl)-4'-(trifluoromethyl)-(1,1'-biphenyl)-2-carboxamide for treatment of obesity, diabetes, and cardiovascular disorders; decreases apoplioprotein secretion |
| 01/22/2004 | US20040014969 Such as methyl-4'-(4-((8-(acetylamino)ethyl)-2-naphthyl)oxy) butoxy)-(1,1'-biphenyl)-4-carboxylate; for treating/ preventing melatoninergic disorders |
| 01/22/2004 | US20040014967 Amide-containing compound having improved solubility and method of improving the solubility of an amide-containing compound |
| 01/22/2004 | US20040014962 Such as (1R,5S,6S)-2-(1-(4-carbamoyl-1,3-thiazol-2-yl)azetidin-3-yl)thio-6-((1R)-1 -hydroxyethyl)-1-methylcarbapen -2-em-3-carboxylic acid for treatment/prevention of bacterial infections |
| 01/22/2004 | US20040014961 Soluble highly branched glucose polymers and their method of production |
| 01/22/2004 | US20040014960 Amidation with chitosans; for prevention of adhesion after surgical operation, correction of facial wrinkles, dermal augmentation, tissue engineering, and osteoarthritic viscosupplement |
| 01/22/2004 | US20040014956 For increasing nuclease resistance of antisense sequences |
| 01/22/2004 | US20040014951 Isostructural pseudopolymorphs of 9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin A |
| 01/22/2004 | US20040014940 Methods for synthesis of acyloxyalkyl derivatives of GABA analogs |
| 01/22/2004 | US20040014899 The method comprises administering to the patient a therapeutically effective amount of a salt of an alkylated and crosslinked polymer. The alkylated and crosslinked polymer salt comprises the reaction product of crosslinked polymers, |
| 01/22/2004 | US20040014818 Bactericidal preparation |
| 01/22/2004 | US20040014817 Stable dosage forms containing ubiquinones |
| 01/22/2004 | US20040014815 Nateglinide-containing preparation |
| 01/22/2004 | US20040014814 A method of altering the senescence of cells comprising applying to said cells an effective amount of a composition wherein said composition includes N-acetyl-carnosine as an active ingredient. |
| 01/22/2004 | US20040014813 Compositions comprising certain active compounds which are suitable as repellents, and to their use for preventing an infection of humans or of animals by the infectious stages of parasitic flatworms (platyhelminths). |
| 01/22/2004 | US20040014812 Promote production and secretion of mucin in ophthalmic tissues. Therapeutic agents for keratoconjunctival diseases in the present invention comprise farnesylacetic acid or a salt thereof as an active ingredient. |
| 01/22/2004 | US20040014810 Schizophrenia; dyskinesias |
| 01/22/2004 | US20040014809 Novel n-( 2-phenyl-3-aminopropyl)naphtamides |
| 01/22/2004 | US20040014808 Novel derivatives of carnosic acid |
| 01/22/2004 | US20040014806 Methods and compositions for lowering levels of blood lipids |
| 01/22/2004 | US20040014805 Wild apple polyphenol and process for producing the same |
| 01/22/2004 | US20040014803 Antilipemic agents; anticholesterol agents; cardiovascular disorders |
| 01/22/2004 | US20040014802 Aminoindazole derivatives and intermediates, preparation thereof, and pharmaceutical compositions thereof |
| 01/22/2004 | US20040014798 Skin disorders; hormone replacement therapy |
| 01/22/2004 | US20040014797 Hypoglycemic agents; synergistic mixtures |
| 01/22/2004 | US20040014796 Antiinflammatory agents; rheumatic diseases; antitumor agents |
| 01/22/2004 | US20040014795 Calcium channel blockers; cardiovascular disorders; synergistic mixtures |
| 01/22/2004 | US20040014794 Use of hydroxypyridone-derivatives in wound healing |
| 01/22/2004 | US20040014793 Stability in blood |
| 01/22/2004 | US20040014792 Agent for inhibition of cytokine production and agent for inhibition of cell adhesion |
| 01/22/2004 | US20040014791 Hyperglycemic acid; antilipemic agents; antidiabetic agents |
| 01/22/2004 | US20040014790 Tartrate salt of thiazolidinedione derivative |
| 01/22/2004 | US20040014789 Novel glucagon antagonists/inverse agonists |
| 01/22/2004 | US20040014788 Novel uses of combined selective dopamine d2 receptor antagonists and 5-ht receptor agonists |
| 01/22/2004 | US20040014787 Hormone inhibitors; controlling fertility |
| 01/22/2004 | US20040014785 Cardiovascular disorders; antiischemic agents |
| 01/22/2004 | US20040014784 Substituted propargylamines |
| 01/22/2004 | US20040014783 Antiinflammatory agents; autoimmune diseases; rheumatic diseases; anticholesterol agents; cardiovascular disorders |
| 01/22/2004 | US20040014782 Combination therapy for the treatment of diseases involving inflammatory components |
| 01/22/2004 | US20040014779 Testing for immunology response moderators; viricides, antitumor agents |
| 01/22/2004 | US20040014778 Heteroaryl - fused nitrogen heterocycles as therapeutic agents |
| 01/22/2004 | US20040014777 Vision disorders |
| 01/22/2004 | US20040014776 Anticancer agents; cyclin-dependent kinase inhibitor |
| 01/22/2004 | US20040014774 Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase |
| 01/22/2004 | US20040014772 Kidney disease; administering cytochrome antagonist |
| 01/22/2004 | US20040014771 Synergistic mixture of antiserotonin agents and serotonin reuptake inhibitors; analgesics; irritable bowel syndrome |
| 01/22/2004 | US20040014770 Tachykinin antagonist |
| 01/22/2004 | US20040014769 Central nervous system disorders; antidepressants; anxiolytic agents; eating disorders |
| 01/22/2004 | US20040014768 Psychological disorders; schizophrenia |
| 01/22/2004 | US20040014767 Central nervous system diosrders; antidepressants, anxiolytic agents, anxiolytic agents |
| 01/22/2004 | US20040014766 Antidiabetic agents |
| 01/22/2004 | US20040014764 N-myristoyltransferase inhibitor compositions and methods of use |
| 01/22/2004 | US20040014763 beta-sheet mimetics and composition and methods relating thereto |
| 01/22/2004 | US20040014762 Pyrrolopyridazine compounds |
| 01/22/2004 | US20040014761 Treatment of female sexual dysfunction with phosphodiesterase inhibitors |
| 01/22/2004 | US20040014760 4- (2-butylamino) -2, 7-dimethyl-8- (2-methyl-6-methoxypyrid-3-YL) pyrazolo- [1,5-A] -1,3,5-triazine, its enantiomers and pharmaceutically acceptable salts as corticotropin releasing factor receptor ligands |
| 01/22/2004 | US20040014759 6,5-Fused bicyclic heterocycles |
| 01/22/2004 | US20040014758 Benzylcycloalkyl amines as modulators of chemokine receptor activity |
| 01/22/2004 | US20040014757 Method for the treatment or prevention of viral infection using nucleoside analogues |
| 01/22/2004 | US20040014755 Rho-kinase inhibitors |
| 01/22/2004 | US20040014754 Urea substituted imidazoquinolines |
| 01/22/2004 | US20040014752 Antidiabetic agents; dietetics; hypoglycermic agents |
| 01/22/2004 | US20040014751 Antidiabetic agents |
| 01/22/2004 | US20040014750 Therapy, prevention atherosclerosis; cardiovascular disorders; anticholesterol agents; bactericides; prevention infections |
| 01/22/2004 | US20040014749 Sulfhydryl rifamycins and uses thereof |
| 01/22/2004 | US20040014748 Cardiovascular disorders, central nervous susyem disorders |
| 01/22/2004 | US20040014747 CRF receptor antagonists and methods relating thereto |
| 01/22/2004 | US20040014746 Antimicrobial thiadiazinone derivatives and their application for treatment of bacterial infections |
| 01/22/2004 | US20040014745 Amide compounds |
| 01/22/2004 | US20040014744 Anticancer, antitumor agents |
| 01/22/2004 | US20040014743 Mbreast and prostate anticancer agents; viricides; alopecia |
| 01/22/2004 | US20040014741 Dietetics; antidiabetic agents; antiinflammatory agents |
| 01/22/2004 | US20040014740 Compound containing sulfur containing ring; parasiticides |
| 01/22/2004 | US20040014739 Low dosage; anxiolytic agents, psychological disorders, cognition activators |